249

parts of India, and where necessary to hold standards, in connection with
the following therapeutic substances which cannot adequately be tested
by chemical means:—

          (a) Organo metallic compounds.

          (b) Gland products.

          (c) Substances commonly known as vaccines, sera, toxins, anti-
toxins and antigens.

          (d) Vitamin products.

     (2) To undertake the testing of certain organo-metallic compounds,
and other substances which cannot be undertaken in provincial laboratories
and in accordance with a schedule to be approved by the Government of
India.

     (3) To give special training in biochemical and bioassay methods to
qualified analysts.

     (4) To examine and to give expert opinion on the therapeutic sub-
stances submitted by provincial governments.

     (5) To issue periodically bulletins of the progress of its activities, and
of information which may be valuable, to provincial laboratories and
manufacturers.

     (6) To undertake analytical examinations for the assistance of manu-
facturers, for which a prescribed fee will be charged, on the understand-
ing that under no circumstances may any report be used for advertising
purposes.

    12. The Bioassay and Pharmaceutical Sections have already been
established at Calcutta, while the Sera and Vaccines Sections will be
formed at the Central Research Institute, Kasauli, and the Vitamins
Section at the Nutrition Laboratories, Coonoor, as soon as the necessary
preliminary investigations have been completed. The present location of
the various sections of the Drugs Control Laboratory is a temporary one
and must remain undetermined until more experience is gained of the
quality and quantity of work which it will be called upon to carry out.

    13. Control of the manufacture and sale of drugs (chemical and
biological products used for medicinal purposes) as well as of the profes-
sion of pharmacy are matters which must be dealt with by provincial
governments, several of whom already have the matter under serious
consideration. As recommended by the Drugs Enquiry Committee a com-
prehensive Pharmacy Act should enable pharmacists to exercise a control
over their own profession by the formation of a provincial Pharmaceuti-
cal Council who would—

        1. Control the education, examination and registration of pharma-
cists and compounders.

        2. Have power to issue diplomas and licenses to practice, to
pharmacists and compounders.

        3. Exercise disciplinary powers over registered pharmacists and
compounders.